LIR-containing proteins in Danio rerio>> EXPORT DATA
S.No. | Uniprot ID | Start | End | LIR Sequence | PSSM Score ▲ ▼ | Similar LIR Motifs | Molecular Function | Biological Process | Cellular Component |
2651 | Q1LWE6 | 336 | 341 | EDFLPV | 14 | lipid binding (GO:0008289) |
|||
2652 | Q1LWG1 | 255 | 260 | DDFDLV | 17 | Q8MQJ7_DROME(389-394) DDFVLV(5); ULK1_HUMAN(355-360) DDFVMV(4); ULK2_HUMAN(351-356) DDFVLV(5) |
nucleus (GO:0005634) |
||
2653 | Q1LWS2 | 469 | 474 | EDYEDV | 16 | ||||
2654 | Q1LWS2 | 542 | 547 | ASFVEL | 12 | BNI3L_HUMAN(34-39) SSWVEL(4); OPTN_HUMAN(176-181) DSFVEI(4) |
|||
2655 | Q1LX29 | 542 | 547 | DGYELL | 15 | FUND1_HUMAN(16-21) DSYEVL(4) | chromatin binding (GO:0003682) |
||
2656 | Q1LX46 | 45 | 50 | SGYDTL | 14 | ATG4B_HUMAN(6-11) LTYDTL(4) | |||
2657 | Q1LX49 | 11 | 16 | LDWEEI | 22 | Atg19_YEAST(410-415) LTWEEL(4) | |||
2658 | Q1LX53 | 23 | 28 | LSYLSL | 10 | ||||
2659 | Q1LX64 | 46 | 51 | ESFQSL | 11 | ||||
2660 | Q1LX65 | 46 | 51 | ESFQSL | 11 | ||||
2661 | Q1LXB1 | 54 | 59 | RSFDAV | 11 | ||||
2662 | Q1LXC4 | 698 | 703 | RDFLSL | 15 | membrane (GO:0016020) |
|||
2663 | Q1LXI2 | 1221 | 1226 | LEYESL | 12 | motor activity (GO:0003774) |
|||
2664 | Q1LXK2 | 690 | 695 | ESFDFL | 13 | ||||
2665 | Q1LXN7 | 453 | 458 | RTFEKV | 11 | ||||
2666 | Q1LXV6 | 628 | 633 | GMYTPV | 10 | ||||
2667 | Q1LXX4 | 254 | 259 | LEFVLV | 10 | Q8MQJ7_DROME(389-394) DDFVLV(4); ULK2_HUMAN(351-356) DDFVLV(4) |
nucleus (GO:0005634) |
||
2668 | Q1LY77 | 230 | 235 | GSYTPL | 11 | nucleotide binding (GO:0000166) |
chromosome (GO:0005694) |
||
2669 | Q1LYC2 | 1015 | 1020 | FSYVKV | 12 | ||||
2670 | Q1LYE1 | 44 | 49 | SGFTEL | 12 | TBCD5_HUMAN(785-790) SGFTIV(4) | nucleus (GO:0005634) |
||
2671 | Q1LYG0 | 1001 | 1006 | SSFTAV | 10 | TBCD5_HUMAN(785-790) SGFTIV(4) | cell projection (GO:0042995) |
||
2672 | Q1LYG0 | 1061 | 1066 | EVYVSI | 9 | cell projection (GO:0042995) |
|||
2673 | Q1LYI5 | 537 | 542 | LVYLDL | 6 | ||||
2674 | Q1LYL9 | 156 | 161 | GSFDAL | 11 | nucleic acid binding (GO:0003676) |
|||
2675 | Q1LYP4 | 1717 | 1722 | GGFTEL | 11 | nucleus (GO:0005634) |
|||
2676 | Q1MT46 | 706 | 711 | ASYEKV | 11 | membrane (GO:0016020) |
|||
2677 | Q1MT59 | 31 | 36 | LSWDDL | 17 | ||||
2678 | Q1MTD2 | 1099 | 1104 | LMYTLL | 10 | ||||
2679 | Q1MTD2 | 2376 | 2381 | LTYTVL | 11 | ATG4B_HUMAN(6-11) LTYDTL(4) | |||
2680 | Q1MTG4 | 237 | 242 | SSFTDI | 11 | ||||
2681 | Q1RLP7 | 25 | 30 | FDFTVL | 16 | ||||
2682 | Q1RLR9 | 169 | 174 | GGFTVL | 11 | nucleosome (GO:0000786); nucleus (GO:0005634) |
|||
2683 | Q1RLV8 | 134 | 139 | ETFVAL | 12 | nucleic acid binding (GO:0003676) |
|||
2684 | Q1RLZ1 | 188 | 193 | LVYQHL | 6 | ||||
2685 | Q29RB2 | 88 | 93 | PEFTSV | 10 | nucleic acid binding (GO:0003676) |
|||
2686 | Q2I6J0 | 960 | 965 | SDFTEI | 16 | hydrolase activity (GO:0016787) |
cell adhesion (GO:0007155); immune system process (GO:0002376) |
cytoskeleton (GO:0005856); filopodium (GO:0030175); membrane (GO:0016020) |
|
2687 | Q2KN93 | 334 | 339 | EVYQAV | 7 | cell cycle (GO:0007049); cell division (GO:0051301) |
|||
2688 | Q2KN93 | 921 | 926 | PSYTDI | 11 | cell cycle (GO:0007049); cell division (GO:0051301) |
|||
2689 | Q2NNA4 | 67 | 72 | SSFDPV | 11 | ||||
2690 | Q2Q551 | 134 | 139 | KDFLHI | 14 | voltage-gated calcium channel complex (GO:0005891) |
|||
2691 | Q2Q552 | 134 | 139 | KDFLHI | 14 | voltage-gated calcium channel complex (GO:0005891) |
|||
2692 | Q2THW0 | 491 | 496 | LSYDSL | 11 | ATG4B_HUMAN(6-11) LTYDTL(4) | |||
2693 | Q32PM2 | 207 | 212 | SEYTEL | 14 | ||||
2694 | Q3B750 | 84 | 89 | KVFQSI | 6 | ||||
2695 | Q3KRG3 | 172 | 177 | DGWTVV | 20 | ||||
2696 | Q3L0W2 | 179 | 184 | AGWIDV | 16 | ||||
2697 | Q3L1G3 | 164 | 169 | SGFITI | 12 | ||||
2698 | Q49TU3 | 53 | 58 | PTYVAL | 12 | nucleic acid binding (GO:0003676) |
|||
2699 | Q4G5W6 | 16 | 21 | EDFEKI | 16 | RBCC1_HUMAN(700-705) FDFETI(4) | |||
2700 | Q4KME6 | 138 | 143 | RSFDDV | 11 |